New Zealand markets close in 26 minutes
  • NZX 50

    12,165.41
    -46.55 (-0.38%)
     
  • NZD/USD

    0.6345
    +0.0037 (+0.58%)
     
  • NZD/EUR

    0.5908
    +0.0026 (+0.44%)
     
  • ALL ORDS

    7,697.60
    -42.90 (-0.55%)
     
  • ASX 200

    7,491.40
    -38.70 (-0.51%)
     
  • OIL

    78.38
    -0.09 (-0.11%)
     
  • GOLD

    1,890.80
    +0.10 (+0.01%)
     
  • NASDAQ

    12,495.38
    -232.90 (-1.83%)
     
  • FTSE

    7,885.17
    +20.46 (+0.26%)
     
  • Dow Jones

    33,949.01
    -207.68 (-0.61%)
     
  • DAX

    15,412.05
    +91.17 (+0.60%)
     
  • Hang Seng

    21,323.83
    +40.31 (+0.19%)
     
  • NIKKEI 225

    27,479.86
    -126.60 (-0.46%)
     
  • NZD/JPY

    83.2580
    +0.4700 (+0.57%)
     

Gilead's Cancer Program Notches Another Win, But It's Arcus Stock That Surges

Gilead's Cancer Program Notches Another Win, But It's Arcus Stock That Surges

Gilead and Arcus notched another win for their cancer program on Monday, pushing GILD stock briefly to a four-year high as RCUS stock gapped higher.